Inventor · disambiguated record
Scott A. Mitchell
Also filed as: MITCHELL SCOTT · MITCHELL SCOTT A · MITCHELL SCOTT ALLAN
68 granted patents·31 pending applications·1,245 citations·filing 2002–2025
99Inventor score
Files withGILEAD SCIENCES INC18GILEAD CONNECTICUT INC16ENANTA PHARM INC14CGI PHARMACEUTICALS INC13NEUROGEN CORP8
Top patents by PatentIndex Score
99 records- 0198US8450321B26-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitorMITCHELL SCOTT A·Filed 2012·Granted May 28, 2013·159 cites·2 claims
- 0297US9290505B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Mar 22, 2016·23 cites·36 claims
- 0397US9120811B26-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphomaGILEAD CONNECTICUT INC·Filed 2014·Granted Sep 1, 2015·28 cites·10 claims
- 0497US8765761B26-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitorGILEAD CONNECTICUT INC·Filed 2013·Granted Jul 1, 2014·29 cites·7 claims
- 0597US7838523B2Certain substituted amides, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2007·Granted Nov 23, 2010·28 cites·72 claims
- 0696US8796270B2N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitorGILEAD CONNECTICUT INC·Filed 2013·Granted Aug 5, 2014·25 cites·7 claims
- 0796US8748607B2Imidazopyrizine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Jun 10, 2014·34 cites·13 claims
- 0896US8455493B2Imidazopyrazine Syk inhibitorsMITCHELL SCOTT A·Filed 2009·Granted Jun 4, 2013·55 cites·10 claims
- 0996US8440667B2Imidazopyrazine Syk inhibitorsMITCHELL SCOTT A·Filed 2009·Granted May 14, 2013·44 cites·9 claims
- 1096US7393848B2Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compoundsCGI PHARMACEUTICALS INC·Filed 2004·Granted Jul 1, 2008·67 cites·50 claims
- 1195US9796718B26-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD CONNECTICUT INC·Filed 2015·Granted Oct 24, 2017·14 cites·2 claims
- 1295US9567348B2Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2015·Granted Feb 14, 2017·15 cites·2 claims
- 1395US9504684B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·18 cites·30 claims
- 1495US9212191B26-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitorGILEAD CONNECTICUT INC·Filed 2014·Granted Dec 15, 2015·19 cites·7 claims
- 1595US7160885B2Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activityCGI PHARMACEUTICALS INC·Filed 2004·Granted Jan 9, 2007·77 cites·41 claims
- 1694US8962835B2Imidazopyrazine Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Feb 24, 2015·22 cites·8 claims
- 1794US8697699B2Imidazopyrazine SYK inhibitorsMITCHELL SCOTT A·Filed 2012·Granted Apr 15, 2014·27 cites·7 claims
- 1894US7884108B2Certain substituted pyrazinonesCGI PHARMACEUTICALS INC·Filed 2008·Granted Feb 8, 2011·35 cites·44 claims
- 1993US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 2093US7405295B2Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compoundsCGI PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·98 cites·59 claims
- 2192US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 2292US7947835B2Certain substituted amides, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2006·Granted May 24, 2011·27 cites·67 claims
- 2392US7642267B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2007·Granted Jan 5, 2010·20 cites·21 claims
- 2492US7189723B2Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activityCGI PHARMACEUTICALS INC·Filed 2004·Granted Mar 13, 2007·48 cites·35 claims
- 2591US11739101B2Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereofNURIX THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·3 cites·40 claims
- 2691US10842803B2Imidazopyridines Syk inhibitorsKRONOS BIO INC·Filed 2018·Granted Nov 24, 2020·3 cites·11 claims
- 2791US9968601B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted May 15, 2018·7 cites·53 claims
- 2891US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 2991US7312341B26-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereofCGI PHARMACEUTICALS INC·Filed 2003·Granted Dec 25, 2007·50 cites·82 claims
- 3090US10342794B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD SCIENCES INC·Filed 2018·Granted Jul 9, 2019·5 cites·15 claims
- 3190US8618107B2Pyridone and aza-pyridone compounds and methods of useBARBOSA ANTONIO J M·Filed 2011·Granted Dec 31, 2013·24 cites·30 claims
- 3290US8058446B2Certain substituted amides, method of making, and method of use thereofBLOMGREN PETER A·Filed 2007·Granted Nov 15, 2011·19 cites·32 claims
- 3389US11453681B2Substituted eneoxindoles and uses thereofGILEAD SCIENCES INC·Filed 2020·Granted Sep 27, 2022·2 cites·53 claims
- 3489US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 3589US10093684B2Substituted imidazo[1,2-a]pyrazines as Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Granted Oct 9, 2018·5 cites·10 claims
- 3689US9562056B2Imidazopyridines Syk inhibitorsBLOMGREN PETER A·Filed 2011·Granted Feb 7, 2017·11 cites·7 claims
- 3789US6919340B2Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereofCELLULAR GENOMICS INC·Filed 2003·Granted Jul 19, 2005·54 cites·34 claims
- 3888US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 3988US10092583B2Imidazopyridines Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Oct 9, 2018·5 cites·19 claims
- 4088US10040781B2Tank-binding kinase inhibitor compoundsGILEAD SCIENCES INC·Filed 2015·Granted Aug 7, 2018·3 cites·48 claims
- 4188US7259164B2Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activityCGI PHARMACEUTICALS INC·Filed 2004·Granted Aug 21, 2007·46 cites·42 claims
- 4287US11517570B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineKRONOS BIO INC·Filed 2020·Granted Dec 6, 2022·1 cites·22 claims
- 4387US10828299B2Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD SCIENCES INC·Filed 2019·Granted Nov 10, 2020·3 cites·18 claims
- 4487US7015227B2Certain amino-substituted monocycles as kinase modulatorsCGI PHARMACEUTICALS INC·Filed 2003·Granted Mar 21, 2006·21 cites·6 claims
- 4584US12263163B2Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitorKRONOS BIO INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 4683US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 4783US9931338B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Apr 3, 2018·3 cites·20 claims
- 4881US8426424B2Certain substituted amides, method of making, and method of use thereofBLOMGREN PETER A·Filed 2009·Granted Apr 23, 2013·5 cites·30 claims
- 4980US9505785B2Pyridone and aza-pyridone compounds and methods of useGILEAD CONNECTICUT INC·Filed 2013·Granted Nov 29, 2016·3 cites·37 claims
- 5078US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott A. Mitchell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →